This e-presentation offers an analysis of three key recent rulings by the General Court at the beginning of 2018 (T-235/15, T-718/15 and T-729/15) upholding the EMA (European Medicines Agency) decisions – in accordance with Regulation 1049/2001 on access to documents – to release documents submitted by marketing authorisation holders of medicinal products during the marketing authorisation phase. It also provides useful key insights into the policy of access to documents as opposed to commercial confidential information.
This version of the e-presentation shows the complete e-presentation.
No certificate can be provided for using this version.
The premium version offers free navigation, downloadable slides, MP3 version, offline video version and the seminars background documentation as additional value.
It is also eligble for the acquisition of CPD points.